Childhood obesity, cardiovascular and liver health: a growing epidemic with age

Maria Felicia Faienza, Mariangela Chiarito, Emilio Molina-Molina, Harshitha Shanmugam, Frank Lammert, Marcin Krawczyk, Gabriele D'Amato, Piero Portincasa, Maria Felicia Faienza, Mariangela Chiarito, Emilio Molina-Molina, Harshitha Shanmugam, Frank Lammert, Marcin Krawczyk, Gabriele D'Amato, Piero Portincasa

Abstract

Background: The frequency of childhood obesity has increased over the last 3 decades, and the trend constitutes a worrisome epidemic worldwide. With the raising obesity risk, key aspects to consider are accurate body mass index classification, as well as metabolic and cardiovascular, and hepatic consequences.

Data sources: The authors performed a systematic literature search in PubMed and EMBASE, using selected key words (obesity, childhood, cardiovascular, liver health). In particular, they focused their search on papers evaluating the impact of obesity on cardiovascular and liver health.

Results: We evaluated the current literature dealing with the impact of excessive body fat accumulation in childhood and across adulthood, as a predisposing factor to cardiovascular and hepatic alterations. We also evaluated the impact of physical and dietary behaviors starting from childhood on cardio-metabolic consequences.

Conclusions: The epidemic of obesity and obesity-related comorbidities worldwide raises concerns about the impact of early abnormalities during childhood and adolescence. Two key abnormalities in this context include cardiovascular diseases, and nonalcoholic fatty liver disease. Appropriate metabolic screenings and associated comorbidities should start as early as possible in obese children and adolescents. Nevertheless, improving dietary intake and increasing physical activity performance are to date the best therapeutic tools in children to weaken the onset of obesity, cardiovascular diseases, and diabetes risk during adulthood.

Keywords: Cardiovascular; Childhood; Liver health; Obesity.

Conflict of interest statement

No financial or nonfinancial benefits have been received or will be received from any party related directly or indirectly to the subject of this article.

Figures

Fig. 1
Fig. 1
Factors influencing obesity and its comorbidities

References

    1. de Onis M, Blossner M, Borghi E. Global prevalence and trends of overweight and obesity among preschool children. Am J Clin Nutr. 2010;92:1257–1264. doi: 10.3945/ajcn.2010.29786.
    1. Ng M, Fleming T, Robinson M, Thomson B, Graetz N, Margono C, et al. Global, regional, and national prevalence of overweight and obesity in children and adults during 1980–2013: a systematic analysis for the global burden of disease study 2013. Lancet. 2014;384:766–781. doi: 10.1016/S0140-6736(14)60460-8.
    1. Wu Y. Overweight and obesity in China. BMJ. 2006;333:362–363. doi: 10.1136/bmj.333.7564.362.
    1. Hales CM, Carroll MD, Fryar CD, Ogden CL. Prevalence of obesity among adults and youth: United States, 2015–2016. NCHS Data Brief. 2017;(288):1–8.
    1. Kumar S, Kelly AS. Review of childhood obesity: from epidemiology, etiology, and comorbidities to clinical assessment and treatment. Mayo Clin Proc. 2017;92:251–265. doi: 10.1016/j.mayocp.2016.09.017.
    1. Palasciano G, Portincasa P, Vinciguerra V, Velardi A, Tardi S, Baldassarre G, et al. Gallstone prevalence and gallbladder volume in children and adolescents: an epidemiological ultrasonographic survey and relationship to body mass index. Am J Gastroenterol. 1989;84:1378–1382.
    1. Simmonds M, Burch J, Llewellyn A, Griffiths C, Yang H, Owen C, et al. The use of measures of obesity in childhood for predicting obesity and the development of obesity-related diseases in adulthood: a systematic review and meta-analysis. Health Technol Assess. 2015;19:1–336. doi: 10.3310/hta19430.
    1. Speiser PW, Rudolf MC, Anhalt H, Camacho-Hubner C, Chiarelli F, Eliakim A, et al. Childhood obesity. J Clin Endocrinol Metab. 2005;90:1871–1887. doi: 10.1210/jc.2004-1389.
    1. Ravelli AC, van Der Meulen JH, Osmond C, Barker DJ, Bleker OP. Obesity at the age of 50 y in men and women exposed to famine prenatally. Am J Clin Nutr. 1999;70:811–816. doi: 10.1093/ajcn/70.5.811.
    1. Di Ciaula A, Portincasa P. Fat epigenome and pancreatic diseases. Interplay and common pathways from a toxic and obesogenic environment. Eur J Intern Med. 2014;25:865–873. doi: 10.1016/j.ejim.2014.10.012.
    1. Di Ciaula A, Portincasa P. Diet and contaminants: driving the rise to obesity epidemics? Curr Med Chem. 2019;26:3471–3482. doi: 10.2174/0929867324666170518095736.
    1. Wang Z, Zou Z, Wang S, Yang Z, Ma J. Chinese famine exposure in infancy and metabolic syndrome in adulthood: results from the China health and retirement longitudinal study. Eur J Clin Nutr. 2019;73:724–732. doi: 10.1038/s41430-018-0211-1.
    1. Marzano F, Faienza MF, Caratozzolo MF, Brunetti G, Chiara M, Horner DS, et al. Pilot study on circulating miRNA signature in children with obesity born small for gestational age and appropriate for gestational age. Pediatr Obes. 2018;13:803–811. doi: 10.1111/ijpo.12439.
    1. Faienza MF, Santoro N, Lauciello R, Calabro R, Giordani L, Di Salvo G, et al. IGF2 gene variants and risk of hypertension in obese children and adolescents. Pediatr Res. 2010;67:340–344. doi: 10.1203/PDR.0b013e3181d22757.
    1. Faienza MF, Acquafredda A, Tesse R, Luce V, Ventura A, Maggialetti N, et al. Risk factors for subclinical atherosclerosis in diabetic and obese children. Int J Med Sci. 2013;10:338–343. doi: 10.7150/ijms.5181.
    1. Nacci C, Leo V, De Benedictis L, Carratu MR, Bartolomeo N, Altomare M, et al. Elevated endothelin-1 (ET-1) levels may contribute to hypoadiponectinemia in childhood obesity. J Clin Endocrinol Metab. 2013;98:E683–E693. doi: 10.1210/jc.2012-4119.
    1. Ciccone MM, Faienza MF, Altomare M, Nacci C, Montagnani M, Valente F, et al. Endothelial and metabolic function interactions in overweight/obese children. J Atheroscler Thromb. 2016;23:950–959. doi: 10.5551/jat.31740.
    1. Giordano P, Del Vecchio GC, Cecinati V, Delvecchio M, Altomare M, De Palma F, et al. Metabolic, inflammatory, endothelial and haemostatic markers in a group of Italian obese children and adolescents. Eur J Pediatr. 2011;170:845–850. doi: 10.1007/s00431-010-1356-7.
    1. Faienza MF, Francavilla R, Goffredo R, Ventura A, Marzano F, Panzarino G, et al. Oxidative stress in obesity and metabolic syndrome in children and adolescents. Horm Res Paediatr. 2012;78:158–164. doi: 10.1159/000342642.
    1. Daniels SR, Arnett DK, Eckel RH, Gidding SS, Hayman LL, Kumanyika S, et al. Overweight in children and adolescents: pathophysiology, consequences, prevention, and treatment. Circulation. 2005;111:1999–2012. doi: 10.1161/01.CIR.0000161369.71722.10.
    1. Faienza MF, Wang DQ, Fruhbeck G, Garruti G, Portincasa P. The dangerous link between childhood and adulthood predictors of obesity and metabolic syndrome. Intern Emerg Med. 2016;11:175–182. doi: 10.1007/s11739-015-1382-6.
    1. WHO Multicentre Growth Reference Study Group WHO Child Growth Standards based on length/height, weight and age. Acta Paediatr Suppl. 2006;450:76–85.
    1. de Onis M, Onyango AW, Borghi E, Siyam A, Nishida C, Siekmann J. Development of a WHO growth reference for school-aged children and adolescents. Bull World Health Organ. 2007;85:660–667. doi: 10.2471/BLT.07.043497.
    1. de Onis M, Lobstein T. Defining obesity risk status in the general childhood population: which cut-offs should we use? Int J Pediatr Obes. 2010;5:458–460. doi: 10.3109/17477161003615583.
    1. de Onis M, Martinez-Costa C, Nunez F, Nguefack-Tsague G, Montal A, Brines J. Association between WHO cut-offs for childhood overweight and obesity and cardiometabolic risk. Public Health Nutr. 2013;16:625–630. doi: 10.1017/S1368980012004776.
    1. Cacciari E, Milani S, Balsamo A, Spada E, Bona G, Cavallo L, et al. Italian cross-sectional growth charts for height, weight and BMI (2 to 20 yr) J Endocrinol Invest. 2006;29:581–593. doi: 10.1007/BF03344156.
    1. Valerio G, Balsamo A, Baroni MG, Brufani C, Forziato C, Grugni G, et al. Childhood obesity classification systems and cardiometabolic risk factors: a comparison of the Italian, World Health Organization and International Obesity Task Force References. Ital J Pediatr. 2017;43:19. doi: 10.1186/s13052-017-0338-z.
    1. Flegal KM, Ogden CL, Yanovski JA, Freedman DS, Shepherd JA, Graubard BI, et al. High adiposity and high body mass index-for-age in US children and adolescents overall and by race-ethnic group. Am J Clin Nutr. 2010;91:1020–1026. doi: 10.3945/ajcn.2009.28589.
    1. Deurenberg P, Bhaskaran K, Lian PL. Singaporean Chinese adolescents have more subcutaneous adipose tissue than Dutch Caucasians of the same age and body mass index. Asia Pac J Clin Nutr. 2003;12:261–265.
    1. Chung S. Body composition analysis and references in children: clinical usefulness and limitations. Eur J Clin Nutr. 2019;73:236–242. doi: 10.1038/s41430-018-0322-8.
    1. Yengo L, Sidorenko J, Kemper KE, Zheng Z, Wood AR, Weedon MN, et al. Meta-analysis of genome-wide association studies for height and body mass index in approximately 700000 individuals of European ancestry. Hum Mol Genet. 2018;27:3641–3649. doi: 10.1093/hmg/ddy271.
    1. Godfrey KM, Reynolds RM, Prescott SL, Nyirenda M, Jaddoe VW, Eriksson JG, et al. Influence of maternal obesity on the long-term health of offspring. Lancet Diabetes Endocrinol. 2017;5:53–64. doi: 10.1016/S2213-8587(16)30107-3.
    1. Twig G, Yaniv G, Levine H, Leiba A, Goldberger N, Derazne E, et al. Body-mass index in 2.3 million adolescents and cardiovascular death in adulthood. N Engl J Med. 2016;374:2430–2440. doi: 10.1056/NEJMoa1503840.
    1. Baker JL, Olsen LW, Sorensen TI. Childhood body-mass index and the risk of coronary heart disease in adulthood. N Engl J Med. 2007;357:2329–2337. doi: 10.1056/NEJMoa072515.
    1. Bjorge T, Engeland A, Tverdal A, Smith GD. Body mass index in adolescence in relation to cause-specific mortality: a follow-up of 230,000 Norwegian adolescents. Am J Epidemiol. 2008;168:30–37. doi: 10.1093/aje/kwn096.
    1. Aune D, Sen A, Prasad M, Norat T, Janszky I, Tonstad S, et al. BMI and all cause mortality: systematic review and non-linear dose-response meta-analysis of 230 cohort studies with 3.74 million deaths among 30.3 million participants. BMJ. 2016;353:i2156. doi: 10.1136/bmj.i2156.
    1. McGill HC, Jr, McMahan CA. Determinants of atherosclerosis in the young. Pathobiological determinants of atherosclerosis in youth (PDAY) research group. Am J Cardiol. 1998;82:30T–36T. doi: 10.1016/S0002-9149(98)00720-6.
    1. Lorenz MW, Markus HS, Bots ML, Rosvall M, Sitzer M. Prediction of clinical cardiovascular events with carotid intima-media thickness: a systematic review and meta-analysis. Circulation. 2007;115:459–467. doi: 10.1161/CIRCULATIONAHA.106.628875.
    1. Faienza MF, Brunetti G, Delvecchio M, Zito A, De Palma F, Cortese F, et al. Vascular function and myocardial performance indices in children born small for gestational age. Circ J. 2016;80:958–963. doi: 10.1253/circj.CJ-15-1038.
    1. Freedman DS, Dietz WH, Tang R, Mensah GA, Bond MG, Urbina EM, et al. The relation of obesity throughout life to carotid intima-media thickness in adulthood: the Bogalusa heart study. Int J Obes Relat Metab Disord. 2004;28:159–166. doi: 10.1038/sj.ijo.0802515.
    1. Juonala M, Raitakari M, Viikari JSA, Raitakari OT. Obesity in youth is not an independent predictor of carotid IMT in adulthood. The cardiovascular risk in young Finns study. Atherosclerosis. 2006;185:388–393. doi: 10.1016/j.atherosclerosis.2005.06.016.
    1. Wright CM, Parker L, Lamont D, Craft AW. Implications of childhood obesity for adult health: findings from thousand families cohort study. BMJ. 2001;323:1280–1284. doi: 10.1136/bmj.323.7324.1280.
    1. Schwimmer JB, Deutsch R, Rauch JB, Behling C, Newbury R, Lavine JE. Obesity, insulin resistance, and other clinicopathological correlates of pediatric nonalcoholic fatty liver disease. J Pediatr. 2003;143:500–505. doi: 10.1067/S0022-3476(03)00325-1.
    1. Angulo P. Nonalcoholic fatty liver disease. N Engl J Med. 2002;346:1221–1231. doi: 10.1056/NEJMra011775.
    1. Tiniakos DG, Vos MB, Brunt EM. Nonalcoholic fatty liver disease: pathology and pathogenesis. Annu Rev Pathol. 2010;5:145–171. doi: 10.1146/annurev-pathol-121808-102132.
    1. Wang DQ, Portincasa P, Neuschwander-Tetri BA. Steatosis in the liver . Compr Physiol. 2013;3:1493–1532. doi: 10.1002/cphy.c130001.
    1. Martins MJ, Ascensao A, Magalhaes J, Collado MC, Portincasa P. Molecular mechanisms of NAFLD in metabolic syndrome. Biomed Res Int. 2015;2015:621080.
    1. Musso G, Gambino R, Cassader M. Cholesterol metabolism and the pathogenesis of non-alcoholic steatohepatitis. Prog Lipid Res. 2013;52:175–191. doi: 10.1016/j.plipres.2012.11.002.
    1. Ventura EE, Davis JN, Goran MI. Sugar content of popular sweetened beverages based on objective laboratory analysis: focus on fructose content. Obesity (Silver Spring). 2011;19:868–874. doi: 10.1038/oby.2010.255.
    1. Lanaspa MA, Sanchez-Lozada LG, Choi YJ, Cicerchi C, Kanbay M, Roncal-Jimenez CA, et al. Uric acid induces hepatic steatosis by generation of mitochondrial oxidative stress: potential role in fructose-dependent and independent fatty liver. J Biol Chem. 2012;287:40732–40744. doi: 10.1074/jbc.M112.399899.
    1. Abdelmalek MF, Suzuki A, Guy C, Unalp-Arida A, Colvin R, Johnson RJ, et al. Increased fructose consumption is associated with fibrosis severity in patients with nonalcoholic fatty liver disease. Hepatology. 2010;51:1961–1971. doi: 10.1002/hep.23535.
    1. Fang YL, Chen H, Wang CL, Liang L. Pathogenesis of non-alcoholic fatty liver disease in children and adolescence: from "two hit theory" to "multiple hit model". World J Gastroenterol. 2018;24:2974–2983. doi: 10.3748/wjg.v24.i27.2974.
    1. Schwimmer JB, McGreal N, Deutsch R, Finegold MJ, Lavine JE. Influence of gender, race, and ethnicity on suspected fatty liver in obese adolescents. Pediatrics. 2005;115:e561–e565. doi: 10.1542/peds.2004-1832.
    1. Lavine JE, Schwimmer JB. Nonalcoholic fatty liver disease in the pediatric population. Clin Liver Dis. 2004;8:549–558. doi: 10.1016/j.cld.2004.04.010.
    1. Anderson EL, Howe LD, Jones HE, Higgins JP, Lawlor DA, Fraser A. The prevalence of non-alcoholic fatty liver disease in children and adolescents: a systematic review and meta-analysis. PLoS One. 2015;10:e0140908. doi: 10.1371/journal.pone.0140908.
    1. Huang JS, Barlow SE, Quiros-Tejeira RE, Scheimann A, Skelton J, Suskind D, et al. Childhood obesity for pediatric gastroenterologists. J Pediatr Gastroenterol Nutr. 2013;56:99–109. doi: 10.1097/MPG.0b013e31826d3c62.
    1. Chalasani N, Younossi Z, Lavine JE, Charlton M, Cusi K, Rinella M, et al. The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases. Hepatology. 2018;67:328–357. doi: 10.1002/hep.29367.
    1. Kinugasa A, Tsunamoto K, Furukawa N, Sawada T, Kusunoki T, Shimada N. Fatty liver and its fibrous changes found in simple obesity of children. J Pediatr Gastroenterol Nutr. 1984;3:408–414. doi: 10.1097/00005176-198406000-00018.
    1. Schwimmer JB, Lavine JE, Wilson LA, Neuschwander-Tetri BA, Xanthakos SA, Kohli R, et al. In children with nonalcoholic fatty liver disease, cysteamine bitartrate delayed release improves liver enzymes but does not reduce disease activity scores. Gastroenterology. 2016;151:1141–1154. doi: 10.1053/j.gastro.2016.08.027.
    1. Lavine JE, Schwimmer JB, Van Natta ML, Molleston JP, Murray KF, Rosenthal P, et al. Effect of vitamin E or metformin for treatment of nonalcoholic fatty liver disease in children and adolescents: the TONIC randomized controlled trial. JAMA. 2011;305:1659–1668. doi: 10.1001/jama.2011.520.
    1. Feldstein AE, Charatcharoenwitthaya P, Treeprasertsuk S, Benson JT, Enders FB, Angulo P. The natural history of non-alcoholic fatty liver disease in children: a follow-up study for up to 20 years. Gut. 2009;58:1538–1544. doi: 10.1136/gut.2008.171280.
    1. Conjeevaram Selvakumar PK, Kabbany MN, Alkhouri N. Nonalcoholic fatty liver disease in children: not a small matter. Paediatr Drugs. 2018;20:315–329. doi: 10.1007/s40272-018-0292-2.
    1. Rashid M, Roberts EA. Nonalcoholic steatohepatitis in children. J Pediatr Gastroenterol Nutr. 2000;30:48–53. doi: 10.1097/00005176-200001000-00017.
    1. Baldridge AD, Perez-Atayde AR, Graeme-Cook F, Higgins L, Lavine JE. Idiopathic steatohepatitis in childhood: a multicenter retrospective study. J Pediatr. 1995;127:700–704. doi: 10.1016/S0022-3476(95)70156-7.
    1. Phatak UP, Pashankar DS. Obesity and gastrointestinal disorders in children. J Pediatr Gastroenterol Nutr. 2015;60:441–445. doi: 10.1097/MPG.0000000000000670.
    1. Franzese A, Vajro P, Argenziano A, Puzziello A, Iannucci MP, Saviano MC, et al. Liver involvement in obese children. Ultrasonography and liver enzyme levels at diagnosis and during follow-up in an Italian population. Dig Dis Sci. 1997;42:1428–1432. doi: 10.1023/A:1018850223495.
    1. Tazawa Y, Noguchi H, Nishinomiya F, Takada G. Serum alanine aminotransferase activity in obese children. Acta Paediatr. 1997;86:238–241. doi: 10.1111/j.1651-2227.1997.tb08881.x.
    1. Vajro P, Fontanella A, Perna C, Orso G, Tedesco M, De Vincenzo A. Persistent hyperaminotransferasemia resolving after weight reduction in obese children. J Pediatr. 1994;125:239–241. doi: 10.1016/S0022-3476(94)70202-0.
    1. Verma S, Jensen D, Hart J, Mohanty SR. Predictive value of ALT levels for non-alcoholic steatohepatitis (NASH) and advanced fibrosis in non-alcoholic fatty liver disease (NAFLD) Liver Int. 2013;33:1398–1405. doi: 10.1111/liv.12226.
    1. Awai HI, Newton KP, Sirlin CB, Behling C, Schwimmer JB. Evidence and recommendations for imaging liver fat in children, based on systematic review. Clin Gastroenterol Hepatol. 2014;12:765–773. doi: 10.1016/j.cgh.2013.09.050.
    1. Bohte AE, Koot BG, van der Baan-Slootweg OH, van Werven JR, Bipat S, Nederveen AJ, et al. US cannot be used to predict the presence or severity of hepatic steatosis in severely obese adolescents. Radiology. 2012;262:327–334. doi: 10.1148/radiol.11111094.
    1. Shannon A, Alkhouri N, Carter-Kent C, Monti L, Devito R, Lopez R, et al. Ultrasonographic quantitative estimation of hepatic steatosis in children with NAFLD. J Pediatr Gastroenterol Nutr. 2011;53:190–195. doi: 10.1097/MPG.0b013e31821b4b61.
    1. Yu EL, Golshan S, Harlow KE, Angeles JE, Durelle J, Goyal NP, et al. Prevalence of nonalcoholic fatty liver disease in children with obesity. J Pediatr. 2019;207:64–70. doi: 10.1016/j.jpeds.2018.11.021.
    1. Kohli R, Sunduram S, Mouzaki M, Ali S, Sathya P, Abrams S, et al. Pediatric nonalcoholic fatty liver disease: a report from the expert committee on nonalcoholic fatty liver disease (ECON) J Pediatr. 2016;172:9–13. doi: 10.1016/j.jpeds.2015.12.016.
    1. Schwimmer JB, Middleton MS, Behling C, Newton KP, Awai HI, Paiz MN, et al. Magnetic resonance imaging and liver histology as biomarkers of hepatic steatosis in children with nonalcoholic fatty liver disease. Hepatology. 2015;61:1887–1895. doi: 10.1002/hep.27666.
    1. Schwimmer JB, Behling C, Angeles JE, Paiz M, Durelle J, Africa J, et al. Magnetic resonance elastography measured shear stiffness as a biomarker of fibrosis in pediatric nonalcoholic fatty liver disease. Hepatology. 2017;66:1474–1485. doi: 10.1002/hep.29241.
    1. Nobili V, Manco M, Ciampalini P, Alisi A, Devito R, Bugianesi E, et al. Metformin use in children with nonalcoholic fatty liver disease: an open-label, 24-month, observational pilot study. Clin Ther. 2008;30:1168–1176. doi: 10.1016/j.clinthera.2008.06.012.
    1. Nobili V, Manco M, Devito R, Di Ciommo V, Comparcola D, Sartorelli MR, et al. Lifestyle intervention and antioxidant therapy in children with nonalcoholic fatty liver disease: a randomized, controlled trial. Hepatology. 2008;48:119–128. doi: 10.1002/hep.22336.
    1. Messing S, Rutten A, Abu-Omar K, Ungerer-Rohrich U, Goodwin L, Burlacu I, et al. How can physical activity be promoted among children and adolescents? A systematic review of reviews across settings. Front Public Health. 2019;7:55. doi: 10.3389/fpubh.2019.00055.
    1. Molina-Molina E, Lunardi Baccetto R, Wang DQ, de Bari O, Krawczyk M, Portincasa P. Exercising the hepatobiliary-gut axis. The impact of physical activity performance. Eur J Clin Invest. 2018;48:e12958. doi: 10.1111/eci.12958.
    1. Jago R, Solomon-Moore E, Macdonald-Wallis C, Sebire SJ, Thompson JL, Lawlor DA. Change in children's physical activity and sedentary time between year 1 and year 4 of primary school in the B-PROACT1V cohort. Int J Behav Nutr Phys Act. 2017;14:33. doi: 10.1186/s12966-017-0492-0.
    1. Pietilainen KH, Kaprio J, Borg P, Plasqui G, Yki-Jarvinen H, Kujala UM, et al. Physical inactivity and obesity: a vicious circle. Obesity (Silver Spring). 2008;16:409–414. doi: 10.1038/oby.2007.72.
    1. Davison KK, Birch LL. Childhood overweight: a contextual model and recommendations for future research. Obes Rev. 2001;2:159–171. doi: 10.1046/j.1467-789x.2001.00036.x.
    1. Barnett TA, Kelly AS, Young DR, Perry CK, Pratt CA, Edwards NM, et al. Sedentary behaviors in today’s youth: approaches to the prevention and management of childhood obesity: a scientific statement from the American Heart Association. Circulation. 2018;138:e142–e159. doi: 10.1161/CIR.0000000000000591.
    1. Goldfield GS, Kenny GP, Hadjiyannakis S, Phillips P, Alberga AS, Saunders TJ, et al. Video game playing is independently associated with blood pressure and lipids in overweight and obese adolescents. PLoS One. 2011;6:e26643. doi: 10.1371/journal.pone.0026643.
    1. Goldfield GS, Saunders TJ, Kenny GP, Hadjiyannakis S, Phillips P, Alberga AS, et al. Screen viewing and diabetes risk factors in overweight and obese adolescents. Am J Prev Med. 2013;44(4 Suppl 4):S364–S370. doi: 10.1016/j.amepre.2012.11.040.
    1. Wennberg P, Gustafsson PE, Dunstan DW, Wennberg M, Hammarstrom A. Television viewing and low leisure-time physical activity in adolescence independently predict the metabolic syndrome in mid-adulthood. Diabetes Care. 2013;36:2090–2097. doi: 10.2337/dc12-1948.
    1. Kobel S, Wartha O, Dreyhaupt J, Kettner S, Steinacker JM. Cross-sectional associations of objectively assessed sleep duration with physical activity, BMI and television viewing in German primary school children. BMC Pediatr. 2019;19:54. doi: 10.1186/s12887-019-1429-3.
    1. Tang A, Ji M, Zhang Y, Zou J, Li M, Yang L, et al. Dietary behaviors and caregiver perceptions of overweight and obesity among Chinese preschool children. Int J Environ Res Public Health. 2018;15:E716. doi: 10.3390/ijerph15040716.
    1. Lipowska M, Lipowski M, Jurek P, Jankowska AM, Pawlicka P. Gender and body-fat status as predictors of parental feeding styles and children's nutritional knowledge, eating habits and behaviours. Int J Environ Res Public Health. 2018;15:E852. doi: 10.3390/ijerph15050852.
    1. Baskin ML, Ard J, Franklin F, Allison DB. Prevalence of obesity in the United States. Obes Rev. 2005;6:5–7. doi: 10.1111/j.1467-789X.2005.00165.x.
    1. Britten P, Marcoe K, Yamini S, Davis C. Development of food intake patterns for the MyPyramid food guidance system. J Nutr Educ Behav. 2006;38(Suppl 6):S78–92. doi: 10.1016/j.jneb.2006.08.007.
    1. Daniels SR, Pratt CA, Hayman LL. Reduction of risk for cardiovascular disease in children and adolescents. Circulation. 2011;124:1673–1686. doi: 10.1161/CIRCULATIONAHA.110.016170.
    1. Mozaffarian D. Dietary and policy priorities for cardiovascular disease, diabetes, and obesity: a comprehensive review. Circulation. 2016;133:187–225. doi: 10.1161/CIRCULATIONAHA.115.018585.
    1. Hills AP, Andersen LB, Byrne NM. Physical activity and obesity in children. Br J Sports Med. 2011;45:866–870. doi: 10.1136/bjsports-2011-090199.
    1. Elmaogullari S, Demirel F, Hatipoglu N. Risk factors that affect metabolic health status in obese children. J Pediatr Endocrinol Metab. 2017;30:49–55. doi: 10.1515/jpem-2016-0128.

Source: PubMed

Спонсоры и соавторы

Заболевания

Медикаментозные вмешательства

Подписаться